Eli Lilly’s Zepbound outperforms Novo’s Wegovy for weight loss in head-to-head trial
Post Content This post first appeared on Healthcare Articles on Seeking Alpha Want to know more about it? Read More
Lilly’s Zepbound is ‘superior’ compared to rival weight loss drug Wegovy
Zepbound is the “superior” choice for people looking to shed a few pounds, at least compared to Novo Nordisk’s (NVO) Wegovy, according to Eli Lilly (LLY). Read more…
STAT+: Eli Lilly says its weight loss drug Zepbound outperformed Wegovy in a study
Eli Lilly said its drug Zepbound led to greater weight reduction than rival Novo Nordisk’s Wegovy in a head-to-head randomized controlled trial.
This weight loss drug helped people shed more pounds than Wegovy, new trial results show
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
(MedPage Today) — The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead recommended switching to…
STAT+: Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Researchers presented new evidence that hormone therapy can be beneficial to menopausal women’s heart health
Why do Ozempic and Wegovy seem to treat everything?
From Alzheimer’s disease to depression to heart disease, Ozempic and other GLP-1 agonist drugs appear to offer a solution. Can one type of drug really tackle so many conditions, and if so, how does it actually work?
Is Bariatric Surgery at Risk of Becoming Obsolete?
With the advent of GLP-1 analogs, does bariatric surgery have a future role in helping people lose weight? Medscape Medical News
ADA Advises Against Using Compounded GLP-1 RA Medications
In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of safety issues. Medscape Medical News
Curbing plastics pollution could help reduce global burden of breast cancer, analysis suggests
A new study suggests addressing plastic pollution could play a critical role not only in protecting the environment, but also in lowering breast cancer rates, which have been increasing globally, especially in younger adults.